Bifikol (Bificol)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceBifidobacteria bifidum + Intestinal sticksBifidobacteria bifidum + Intestinal sticks
Similar drugsTo uncover
  • Bifikol
    lyophilizate inwards 
    MICROGEN FGUP Scientific and Production Association     Russia
  • Bifikol
    lyophilizate inwards 
    BIOMED them. I.I.Mechnikova, OJSC     Russia
  • Bifikol
    lyophilizate inwards 
    BIOMED them. I.I.Mechnikova, OJSC     Russia
    • Dosage form: & nbsplyophilizate for the preparation of a suspension for oral ingestion
    Composition:

    One dose of the drug contains at least 107 live cells of strain M-17 of Escherichia coli and not less than 107 living cells of B. bifidum 1 strain of bifidobacteria, lyophilized in culture medium.

    Description:

    The drug has the form of free-flowing powder whitish-gray with a yellowish tinge. When dissolved with water, forms a turbid suspension. Presence of small flakes. The drug has a specific odor.

    Pharmacotherapeutic group:Eubiotic
    ATX: & nbsp

    A.07.F.A   Antidiarrhoeal preparations of biological origin regulating the balance of intestinal microflora

    Pharmacodynamics:

    The therapeutic effect is due to the antagonistic activity of live bifidobacteria and E. coli, in the ratio of pathogenic and conditionally pathogenic microorganisms, including Shigella, Salmonella, Proteus, etc .; has immunomodulating and adjuvant activity of bacterial antigens affecting the production of specific and nonspecific,including local, protection factors; stimulates local reparative processes in the intestine.

    Indications:

    Treatment of convalescent after acute intestinal infections in the presence of bowel dysfunctions, the isolation of pathogenic bacteria, chronic colitis of various etiologies, dysbacteriosis.

    Contraindications:Specific and nonspecific ulcerative colitis.
    Dosing and Administration:

    The drug is administered orally from 6 months of age 30-40 minutes before meals.

    When the aftercare of reconvalescences after acute intestinal infections, intestinal dysfunction:

    - Children from 6 months to 1 year - 3 doses 2 times a day for 10-14 days;

    - from 1 year to 3 years - 5 doses 1-2 times within 10-14 days;

    - older than 3 years and adults - 2-3 times a day for 14-21 days.

    Treatment of dysbacteriosis, nonspecific and specific chronic colitis:

    - children from 6 months to 1 year for 3 doses 2 times a day for up to 14 days;

    - from 1 year to 3 years - 5 doses 2 times a day for 14-21 days;

    - older than 3 years and adults - 5 doses 2-3 times a day for 3 weeks.

    The size of the daily dose and the duration of treatment is determined by the doctor, depending on the severity, duration of the disease and the severity of dysbiosis. If necessary, treatment courses can be repeated, but not earlier than 2 months after the end of treatment with a preliminary control of the intestinal microbiocenosis.

    The contents of the sachet are diluted with cold boiled water from the calculation of 5 ml (one teaspoon) per dose of the drug. Diluted preparation is not subject to storage.

    Side effects:

    In the process of treatment with bifikol, in rare cases, there may be mild dyspeptic disorders, which usually pass on their own and do not require the withdrawal of the drug or the appointment of treatment. In the case of a more pronounced reaction, temporary discontinuation of the drug or discontinuation of treatment is advisable.

    Interaction:It is not recommended simultaneous appointment of chemo- and antibiotic therapy.
    Form release / dosage:Lyophilizate for preparation of a suspension for oral ingestion.
    Packaging:

    In a bag of 5 doses; 10, 20, 30, 40 or 50 bags in a pack with instructions for use.

    Storage conditions:

    In accordance with SP 3.3.2.1248-03 at a temperature not exceeding 10 ° C, out of reach of children.

    Transportation conditions

    In accordance with SP 3.3.2.1248-03 at a temperature not exceeding 10 ° ะก.

    Unsuitable for use:

    1. The drug, the integrity of the packaging is broken (ripped bags).

    2. The drug is unmarked.

    3. A drug with altered physical properties (color change, sticking of biomass in bags),in the presence of foreign impurities.

    Shelf life:

    1 year.

    The drug with expired shelf life is not subject to application.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-007949/08
    Date of registration:08.10.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:BIOMED them. I.I.Mechnikova, OJSC BIOMED them. I.I.Mechnikova, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp16.02.2017
    Illustrated instructions
      Instructions
      Up